{
    "nct_id": "NCT03146806",
    "official_title": "Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer Related Pain",
    "inclusion_criteria": "* Patients with uncontrolled pain related to cancer or cancer treatment. Uncontrolled pain will be defined as:\n\n  * Pain which persists for more than 7 days and is rated >/=4 on Numerical Pain Rating Score (NPRS)\n  * Use of breakthrough medication more than 4 times in 24 hours or being treated with oral morphine equivalent of 50 mg/d or more\n* Patients who are able to follow-up in person during the trial\n* Patient on stable analgesic regimen for >7 days without escalation during study period with rescue or immediate release medication every 3 hours or longer\n* Patients who are willing and able to maintain a daily pain diary\n* Patients who are able to understand written and verbal English\n* Patient weight >/= 50 kg\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Transportation issues interfering with return study visits\n* Patients with high disposition of laryngospasm or apnea\n* Presence of severe cardiac disease\n* Presence of conditions where significant elevations in blood pressure would be a serious hazard.\n* Stage 2 hypertension or greater (systolic blood pressure > 160 and/or diastolic blood pressure >100)\n* Baseline tachycardia, heart rate (HR) >100\n* History of seizures, elevated intracranial pressure (ICP) or cerebrospinal fluid (CSF) obstructive states (e.g. severe head injury, central congenital or mass lesions)\n* Conditions that may increase intraocular pressure (e.g. glaucoma, acute globe injury)\n* History of uncontrolled depression or other psychiatric comorbidity with psychosis\n* History of liver disease\n* History of interstitial cystitis\n* History of nasal or sinus anomalies or dysfunction e.g. allergic or infectious rhinitis.\n* Patients with lesions to the nasal mucosa\n* Pregnant women, nursing mothers and women of childbearing potential not using contraception known to be highly effective. Highly effective contraception methods include combination of any two of the following:\n\n  * Use of oral, injected or implanted hormonal methods of contraception or;\n  * Placement of an intrauterine device (IUD) or intrauterine system (IUS);\n  * Barrier methods of contraception: condom or occlusive cap (diaphragm or cervical/vault caps) with spermicidal foam/gel/film/cream/ vaginal suppository;\n  * Total abstinence or;\n  * Male/female sterilization.\n* Illicit substance abuse within the past 6 months\n* Documented history of medication abuse/misuse (e.g. Unsanctioned dose escalation, broken opioid agreement etc.)\n* Clinical requirement for medications that are concurrent inducers or inhibitors of CYP3A4. CYP3A4 substrates are allowed.\n* Porphyria (possibility of triggering a porphyric reaction)\n* Severe active anemia ( a hemoglobin< 8 documented by labs drawn within 3 months of first study treatment)\n* History of difficult intravenous access\n* Intractable vomiting",
    "miscellaneous_criteria": ""
}